Cystoid macular edema (CME) is one the most common pathological sequel of the retina causing reversible vision loss and usually occurs after ophthalmic surgery. The most effective treatment strategies for CME include treating the underlying risk factors such as diabetes, blood vessel occlusion, neovascularization, inflammation, etc. It also includes managing an excess of fluid leaking from abnormal blood vessels around the macula. In this regard, Novartis Ophtha-Center and Docplexus have organized an interactive LIVE webinar on 1 st August 2020, Saturday, 7.30 PM onwards . In this webinar, globally renowned ophthalmologist Dr.
Rishi Paul Singh will throw light on Dissecting and Treating Cystoid Macular Edema. Dr. Partha Biswas will moderate the webinar. The agenda of the webinar is as follows: We invite you to share your questions, which will be answered by the speakers at the end…
